@FierceMedDev: Life Tech buys Korean distributor as Thermo waits. News | Follow @FierceMedDev
@DamianFierce: Venture-backed Natera is expanding its prenatal test as it contends with $SQNM, $ILMN and others. Article | Follow @DamianFierce
@MarkHFierce: Just met in Berlin with Christian Pangratz, CBO of Activaero, which has a promising drug-device liquid inhalation treatment for asthma. | Follow @MarkHFierce
@MichaelGFierce: Chime in on the nano-gold discussion at the FierceBiotech LinkedIn page: Discussion | Follow @MichaelGFierce
> The American Clinical Laboratory Association is trying to stop the FDA's push to regulate laboratory-developed tests as medical devices. Story
> The FDA slapped a Class I recall status--its most serious label--on Symbios' GoPump Rapid Recovery System, a disposable pain-management device that includes a small balloon. Notice
> Amarantus Bioscience Holdings sealed a deal with BD Biosciences allowing BD to analyze samples for Amarantus' LymPro test for Alzheimer's disease. Item
> AngioScore won FDA approval of a PMA supplement labeling change, allowing the inclusion of a clinical trial results summary on its AngioSculpt PTCA Scoring Balloon angioplasty catheter's instructions for use. Item
> VentureHealth is rolling out an online equity crowdfunding platform for life sciences companies. Story
> Abyrx won FDA clearance for its new absorbable hemostatic bone putty, which comes ready-to-use. Item
> NASA launched a new funding program designed to spur healthcare/med tech entrepreneurs to develop healthcare products useable in space and on earth. Story
> Spectral MD is touting a new FDA 510(k) clearance for its DeepView medical imaging system, for studies of blood flow in microcirculation. Item
Biotech News
@FierceBiotech: Report: Genomics industry contributed $1 trillion to U.S. economy in last 25 years. Article | Follow @FierceBiotech
@JohnCFierce: Royalty Pharma scrambles to salvage vote on hostile Elan takeover. Story | Follow @JohnCFierce
@RyanMFierce: GSK has halted a study of an MS compound linked to data fraud in China. The plot thickens. More | Follow @RyanMFierce
@EmilyMFierce: SCOTUS decision on Myriad case: Natural isolated DNA is not patentable. Synthetic DNA is patentable because it doesn't occur naturally. | Follow @EmilyMFierce
> Japanese biotech Prism snags $15M C round for cancer, fibrosis studies. News
> Lilly's oral rheumatoid arthritis blockbuster contender champions 1-year study. News
> Glaxo's dismissed China R&D chief fires back. Article
Pharma News
@FiercePharma: Catalent kicks off $35M expansion in U.S. More | Follow @FiercePharma
@EricPFierce: Novo suggests overzealous reading of risks of Type 2 diabetes drugs that include Victoza, Januvia. Article | Follow @EricPFierce
@CarlyHFierce: Insider trading charges from Sanofi/Chattem deal continue to pile up. Brothers allegedly scored a $50k profit. Report | Follow @CarlyHFierce
> GSK probes sales tactics in China days after firing R&D chief there. More
> AARP fears Pfizer tactics to defend Lipitor could become model. Story
Pharma Manufacturing News
> Zydus recalls warfarin after oversized tablets discovered. Item
> FedEx vows not to settle with feds on online pharmacy shipments. Story
> FDA warning letter nails 2 Baxter plants for repeat violations. Article
> FDA comes down on another Indian drugmaker. Report
Vaccines News
> Latin American cancer vax races Big Pharma rivals. More
> FDA clears Sanofi to compete for 4-in-1 flu vaccine market. Report
> FDA setback sends Dynavax shares tumbling again. Article
> Oral vaccine aims to end dreaded Delhi belly. Story